Sexually Transmitted Diseases Testing Market Size to Hit USD 16.68 Billion

The global sexually transmitted diseases testing market size was valued at USD 8.80 billion in 2022. The market is projected to grow from USD 9.52 billion in 2023 to USD 16.68 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period.

Sexually Transmitted Diseases (STDs) are infections caused by viruses, parasites, or bacteria, which are transmitted through sexual contact, including oral sex, vaginal, and anal. It may also get transmitted vertically, that is, from mother to child, during breastfeeding, childbirth, and pregnancy.

Fortune Business Insights™ mentioned this in a report titled “Sexually Transmitted Diseases Testing Market, 2023-2030.”

Request a Free Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/sample/sexually-transmitted-diseases-testing-market-101095

Key Takeaways:

  • Regulatory scenario for key countries
  • Pipeline analysis
  • Technological advancements in sexually transmitted diseases devices
  • Prevalence of sexually transmitted diseases by key countries
  • PESTEL analysis
  • Recent industry developments such as partnerships, mergers, and acquisitions
  • Overview of new product launches in sexually transmitted diseases testing

List of Key Players Present in the Report:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Abbott (U.S.)
  • BD (U.S.)
  • Hologic, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • bioMerieux, Inc. (France)
  • Cepheid (Danaher Corporation) (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • DiaSorin S.p.A (Italy)

COVID-19 Impact-

Decrease in Number of Reported Cases during COVID-19 Impacted the Market Growth Adversely

The sudden outbreak of the pandemic has impacted the market adversely owing to a decrease in STD testing, which accounted for an increase in underreported cases and an increase in transmission of these diseases. The prominent players in the market witnessed a decrease in their segmental revenue growth in FY 2020, owing to the outbreak of the novel COVID-19 pandemic.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/industry-reports/sexually-transmitted-diseases-testing-market-101095

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245Email:sales@fortunebusinessinsights.com

Comments

Popular posts from this blog

Pulse Oximeters Market Rising in United States | Fortune Business Insights

Medical Robotic Systems Market Rising in United States | Fortune Business Insights

Implantable Cardioverter Defibrillator Industry Growth and Restrain Factors 2024